Value of High Field Tntensity MRIT1 Perfusion Imaging Combined with DWI Imaging in Evaluating The Efficacy of Neoadjuvant Chemotherapy for Breast Cancer

Zheng ZHANG; Yanhong YANG; Zaihui FENG; Lujiang ZHAN; Jinxian PU; Qianting DUAN

doi:10.12259/j.issn.2095-610X.S20240722

Volume 45 Issue 7

Jul. 2024

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2024 > 45(7): 148-153

Zheng ZHANG, Yanhong YANG, Zaihui FENG, Lujiang ZHAN, Jinxian PU, Qianting DUAN. Value of High Field Tntensity MRIT1 Perfusion Imaging Combined with DWI Imaging in Evaluating The Efficacy of Neoadjuvant Chemotherapy for Breast Cancer[J]. Journal of Kunming Medical University, 2024, 45(7): 148-153. doi: 10.12259/j.issn.2095-610X.S20240722

Citation:

Zheng ZHANG, Yanhong YANG, Zaihui FENG, Lujiang ZHAN, Jinxian PU, Qianting DUAN. Value of High Field Tntensity MRIT1 Perfusion Imaging Combined with DWI Imaging in Evaluating The Efficacy of Neoadjuvant Chemotherapy for Breast Cancer[J]. Journal of Kunming Medical University, 2024, 45(7): 148-153. doi: 10.12259/j.issn.2095-610X.S20240722

Citation:

Zheng ZHANG, Yanhong YANG, Zaihui FENG, Lujiang ZHAN, Jinxian PU, Qianting DUAN. Value of High Field Tntensity MRIT1 Perfusion Imaging Combined with DWI Imaging in Evaluating The Efficacy of Neoadjuvant Chemotherapy for Breast Cancer[J]. Journal of Kunming Medical University, 2024, 45(7): 148-153. doi: 10.12259/j.issn.2095-610X.S20240722

PDF( 576 KB)

Value of High Field Tntensity MRIT1 Perfusion Imaging Combined with DWI Imaging in Evaluating The Efficacy of Neoadjuvant Chemotherapy for Breast Cancer

doi: 10.12259/j.issn.2095-610X.S20240722

Dept. of Radiology，The 3rd People’s Hospital of Honghe Prefecture，Gejiu Yunnan 661000，China

Received Date: 2024-02-28
Available Online: 2024-06-14
Publish Date: 2024-07-25

Abstract

Abstract

Objective To assess the potential value of high-field MRI T1 perfusion imaging combined with diffusion-weighted imaging （DWI） in evaluating neoadjuvant chemotherapy efficacy in breast cancer. Methods The clinical and radiological data, including pre-and post-chemotherapy T1 perfusion imaging and DWI imaging data, were retrospectively collected from 126 breast cancer patients. Multifactorial logistic regression analysis was used to investigate the relationship between different imaging parameters and neoadjuvant chemotherapy efficacy, and a predictive model was established. Results T1 perfusion parameters and DWI imaging parameters （area under the curve, time to peak, washing, maxenh, ADC value） were all related factors in evaluating the efficacy of neoadjuvant chemotherapy for breast cancer （P < 0.05）. The multifactorial logistic regression model based on these correlated parameters achieved an accuracy of 91.3% in predicting chemotherapy efficacy. Conclusions MRI T1 perfusion imaging combined with DWI imaging holds potential clinical application prospects in assessing neoadjuvant chemotherapy efficacy in breast cancer. Comprehensive analysis of MRI T1 perfusion imaging combined with DWI imaging parameters allows for a more accurate prediction of breast cancer patients' response to treatment, providing robust support for treatment decisions.
- Magnetic resonance perfusion imaging,
- Diffusion-weighted imaging,
- Breast cancer,
- Neoadjuvant chemotherapy

FullText(HTML)

References(16)

References

[1]	Sung H,Ferlay J,Siegel R L,et al. Global cancer statistics 2020: GLOBOCAN estimates of Incidence and mortality worldwide for 36 cancers in 185 countries[J]. Ca Cancer J Clin,2021,71(3):209-249. doi: 10.3322/caac.21660
[2]	Malveiro C,Correia I R,Cargaleiro C,et al. Effects of exercise training on cancer patients undergoing neoadjuvant treatment: A systematic review[J]. J Sci Med Sport,2023,26(11):586-592. doi: 10.1016/j.jsams.2023.08.178
[3]	Cortazar P,Zhang L,Untch M,et al. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis[J]. Lancet,2014,384(9938):164-172. doi: 10.1016/S0140-6736(13)62422-8
[4]	D í az C,Gonz á lez-Olmedo C,D í az-Beltrán L,et al. Predicting dynamic response to neoadjuvant chemotherapy in breast cancer: A novel metabolomics approach[J]. Mol Oncol,2022,16(14):2658-2671. doi: 10.1002/1878-0261.13216
[5]	Fisusi F A,Akala E O. Drug Combinations in Breast Cancer Therapy[J]. Pharm Nanotechnol,2019,7(1):3-23. doi: 10.2174/2211738507666190122111224
[6]	Zhang M,Horvat J V,Bernard-Davila B,et al. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy[J]. J Magn Reson Imaging,2018,49(3):864-874.
[7]	Park G E,Kang B J,Kim S H,et al. The role of diffusion-weighted imaging based on maximum-intensity projection in young patients with marked background parenchymal enhancement on contrast-enhanced breast MRI[J]. Life (basel),2023,13(8):1744-1758. doi: 10.3390/life13081744
[8]	Hu X Y,Li Y,Jin G Q,et al. Diffusion-weighted MR imaging in prediction of response to neoadjuvant chemotherapy in patients with breast cancer[J]. Oncotarget,2017,8(45):79642-79649. doi: 10.18632/oncotarget.18999
[9]	Huang Z,Chen X,Jiang N,et al. A clinical radiomics nomogram preoperatively to predict ductal carcinoma in situ with microinvasion in women with biopsy-confirmed ductal carcinoma in situ: a preliminary study[J]. Bmc Med Imaging,2023,23(1):118-130. doi: 10.1186/s12880-023-01092-5
[10]	Iannessi A,Beaumont H,Liu Y,et al. RECIST 1.1 and lesion selection: How to deal with ambiguity at baseline?[J]. Insights Imaging,2021,12(1):36-44. doi: 10.1186/s13244-021-00976-w
[11]	Scaranelo A M. What’ s hot in breast MRI[J]. Can Assoc Radiol J,2022,73(1):125-140. doi: 10.1177/08465371211030944
[12]	Leithner D,Moy L,Morris E A,et al. Abbreviated MRI of the breast: Does it provide value?[J]. J Magn Reson Imaging,2018,49(7):e85-e100.
[13]	Tran W T,Sadeghi-Naini A,Lu F I,et al. Computational radiology in breast cancer screening and diagnosis using artificial intelligence[J]. Can Assoc Radiol J,2020,72(1):98-108.
[14]	Saha M,Mukherjee R,Chakraborty C. Computer-aided diagnosis of breast cancer using cytological images: A systematic review[J]. Tissue Cell,2016,48(5):461-474. doi: 10.1016/j.tice.2016.07.006
[15]	Satake H,Ishigaki S,Ito R,et al. Radiomics in breast MRI: current progress toward clinical application in the era of artificial intelligence[J]. Radiol Med,2021,127(1):39-56.
[16]	Xu H D,Zhang Y Q. Evaluation of the efficacy of neoadjuvant chemotherapy for breast cancer using diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging[J]. Neoplasma,2017,64(3):430-436. doi: 10.4149/neo_2017_314

Relative Articles(20)

Relative Articles

[1]	Jing LIU, Mei YAN, Yashuang CHEN, Liyu DU, Sisi HUANG. Survey and Analysis of Supportive Care Needs of Patients after Radical Breast Cancer Surgery based on Kano Model. Journal of Kunming Medical University, 2023, 44(11): 188-194. doi: 10.12259/j.issn.2095-610X.S20231129
[2]	Siqi XIE, Hengyu ZHANG, Hongwan LI, Mingjian TAN, Qing WANG, Sijia LI, Kai ZHENG, Dequan LIU, Shicong TANG. Correlation between Serum Valine and Methionine Levels and Clinical Features and Risk of Breast Cancer. Journal of Kunming Medical University, 2022, 43(8): 47-55. doi: 10.12259/j.issn.2095-610X.S20220807
[3]	Jiawei LIAO, Xiaoqing HU, Yi YANG. Changes of Thyroid Function and Its Clinical Significance before and after Radiotherapy and Chemotherapy in Patients Undergoing Radical Breast Cancer Treatment. Journal of Kunming Medical University, 2022, 43(2): 72-77. doi: 10.12259/j.issn.2095-610X.S20220229
[4]	Wen-jing SUN, Man-ting HU, Na LI, Fei GE, Wen-lin CHEN, Yang LIU. Progress in Clinical Research on Drug Resistance and Reversal of Endocrine Therapy in Breast Cancer. Journal of Kunming Medical University, 2021, 42(7): 143-149. doi: 10.12259/j.issn.2095-610X.S20210724
[5]	Jiang ZHANG, Yan LIU, Wen-hui LI, Xi-juan ZHAO, Zheng-ting CHEN, Qiong-yao GUAN, Jiang WU. Effects of Pre-sleep Music Therapy on Sleep Quality and Cancer-related Fatigue in Patients with Breast Cancer Undergoing Radiotherapy. Journal of Kunming Medical University, 2020, 41(12): 173-178. doi: 10.12259/j.issn.2095-610X.S20201248
[6]	Li Chen , Yang Ming Ying , Duan Wen Jing , Jiang Ai Mei , Huang Qi , Yang Xue Fang . A Screening of Pre-chemotherapy Psychological Distress in Breast Cancer Patients and An Analysis of the Influencing Factors. Journal of Kunming Medical University, 2018, 39(08): 33-38.
[7]	Li Ning , Xu Miao , Zhang Wei , Zhang Qing , Kong Ying . Clinical Significance of Serum Vitamin D Levels Change in Patients with Breast Cancer before and after Chemoradiotherapy. Journal of Kunming Medical University, 2018, 39(08): 108-112.
[8]	Zhao Yun Hong , Fu Da Gan , Tang Yi Yin , Hao Fang , Shi Qiao Ming , Zhang Li Juan . . Journal of Kunming Medical University, 2017, 38(03): 51-54.
[9]	Wang Yi Ming , Yang Yue . Comparison of the Diagnosis Significance for Breast Cancer between Single High Frequency Ultrasonography and Mammography. Journal of Kunming Medical University, 2017, 38(06): 48-51.
[10]	Xu Xiao Hong . Clinical Analysis of Preoperative Neoadjuvant Chemotherapy by Thalidomide Combined with Gefitinib for Non-small Cell Lung Cancer. Journal of Kunming Medical University,
[11]	Zhu Tian Bo . Clinical Application of Preoperative New Adjuvant Chemotherapy in Treatment of Cervical Cancer. Journal of Kunming Medical University,
[12]	Li Zhuo Lin . Assessment of Locally Advanced Breast Cancer Response to Neoadjuvant Chemotherapy with Diffusion weighted MRI. Journal of Kunming Medical University,
[13]	Li Yun Fen . . Journal of Kunming Medical University,
[14]	Li Xiao Yong . . Journal of Kunming Medical University,
[15]	Wang Jian Kui . . Journal of Kunming Medical University,
[16]	Zhao Chun Fang . . Journal of Kunming Medical University, 2013, 34(01): 1-1.
[17]	Yang Jing . . Journal of Kunming Medical University,
[18]	Wu Zhi Yong . . Journal of Kunming Medical University,
[19]	Li Kun Lun . Effect of Survivin Gene Expression Inhibition by RNAi on Breast Cancer SKBr-3 Cells. Journal of Kunming Medical University,
[20]	. . Journal of Kunming Medical University,